Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» plecanatide
plecanatide
Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
Did 50 Salespeople Leave Valeant? Wells Fargo Investigates
Barron's
Valeant Pharmaceutcals
drug reps
Synergy Pharmaceuticals
plecanatide
Flag link:
Can 'Santa Claus' Rally Continue For These 3 Small Biotechs?
Can 'Santa Claus' Rally Continue For These 3 Small Biotechs?
Seeking Alpha
biotech
Portola
betrixaban
Synergy Pharmaceuticals
plecanatide
Progenics
prostate cancer
Flag link:
All Eyes on These Two Biotech Firms Ahead of FDA Decisions
All Eyes on These Two Biotech Firms Ahead of FDA Decisions
Investopedia
FDA
biotech
MACI
Vericel Corporation
chronic idiopathic constipation
Synergy Pharmaceuticals
plecanatide
Flag link:
Synergy Pharmaceuticals Sinks on FDA Update
Synergy Pharmaceuticals Sinks on FDA Update
24/7 Wall St
Synergy Pharmaceuticals
FDA
chronic idiopathic constipation
IBS-C
plecanatide
Flag link:
3 Risky Biotechs With FDA Decisions On Deck
3 Risky Biotechs With FDA Decisions On Deck
Motley Fool
FDA
Sarepta Therapeutics
eteplirsen
Synergy Pharmaceuticals
plecanatide
Celator
Vyxeos
Flag link:
3 Big Battles Brewing in Biotech
3 Big Battles Brewing in Biotech
Motley Fool
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Flag link:
Is This Ironwood Pharmaceuticals' Biggest Threat?
Is This Ironwood Pharmaceuticals' Biggest Threat?
Motley Fool
Ironwood Pharmaceuticals
Linzess
plecanatide
Synergy Pharmaceuticals
Flag link:
Synergy's Looming FDA Filing Makes It Pharma of the Month
Synergy's Looming FDA Filing Makes It Pharma of the Month
TheStreet.com
Synergy Pharmaceuticals
FDA
plecanatide
Flag link:
4 Key FDA Decisions Expected in November and December
4 Key FDA Decisions Expected in November and December
24/7 Wall St
FDA
Androxal
Repros Therapeutics
elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide
OPuS-2
Biocryst
Synergy Pharmaceuticals
plecanatide
Flag link:
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
Flag link:
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains
24/7 Wall St
Synergy Pharmaceuticals
chronic idiopathic constipation
plecanatide
Flag link:
Synergy soars on stellar constipation data, rekindling buyout chatter
Synergy soars on stellar constipation data, rekindling buyout chatter
Fierce Biotech
Synergy Pharmaceuticals
plecanatide
constipation
M&A
Flag link:
Synergy Pharma Said to Consider Sale Ahead of Trial Results
Synergy Pharma Said to Consider Sale Ahead of Trial Results
Bloomberg
Synergy Pharmaceuticals
M&A
plecanatide
Flag link:
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Synergy Pharmaceuticals
plecanatide
IBS-C
Flag link:
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Previous Data Signals Positive Phase IIb Results Likely To Come For Synergy Pharmaceuticals
Seeking Alpha
Synergy Pharmaceuticals
IBS-C
Ironwood Pharmaceuticals
Linzess
Sucampo
plecanatide
Flag link:
Biotechs With Near-Term Catalysts That Should Rally
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Ampio
Avanir
Chelsea Therapeutics
Endo Health Solutions
Optina
Northera
Synergy Pharmaceuticals
plecanatide
AVP-825
vintafolide
Flag link:
Synergy Pharma Progresses with Plecanatide
Synergy Pharma Progresses with Plecanatide
Yahoo/Zacks.com
Synergy Pharmaceuticals
plecanatide
IBS-C
Flag link:
4 Healthcare Stock Stories Making Midweek Headlines
4 Healthcare Stock Stories Making Midweek Headlines
Wall St Cheat Sheet
BAX 855
Baxter International
plecanatide
Synergy Pharmaceuticals
layoffs
Transcept
NPS Pharmaceuticals
Gattex
Flag link:
Synergy sees initiating phase 3 program for plecanatide in CIC in Q4
Synergy sees initiating phase 3 program for plecanatide in CIC in Q4
Yahoo/Fly on the Wall
Synergy Pharmaceuticals
plecanatide
chronic idiopathic constipation
Flag link:
Pipeline Progress at Synergy Pharma
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Synergy Pharmaceuticals
irritable bowel syndrome
plecanatide
Flag link:
Pages
1
2
next ›
last »